Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Edward Tackey
Tocilizumab in Systemic Lupus Erythematosus: Data on Safety, Preliminary Efficacy, and Impact on Circulating Plasma Cells From an Open-Label Phase I Dosage-Escalation Study
Arthritis & Rheumatism
Related publications
SAT0231 Safety of Subcutaneous Belimumab in Patients With Systemic Lupus Erythematosus: A 6-Month Open-Label Extension Study
The Maraviroc Expanded Access Program — Safety and Efficacy Data From an Open-Label Study
HIV Clinical Trials
Phase I, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of GSK2879552 in Relapsed/Refractory Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Plasma Exchange in Systemic Lupus Erythematosus.
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Type I Interferon and Systemic Lupus Erythematosus
Journal of Interferon and Cytokine Research
Medicine
Virology
Immunology
Cell Biology
A Study of the Efficacy of Immunosuppressants on Clinical Course of Systemic Lupus Erythematosus.
Japanese Journal of Clinical Immunology
A Study on Cardiovascular Manifestations of Systemic Lupus Erythematosus
Journal of Evolution of Medical and Dental Sciences
Efficacy and Safety of Two Ayurvedic Dosage Forms for Allergic Rhinitis: Study Protocol for an Open-Label Randomized Controlled Trial
Trials
Medicine
Pharmacology
Cutting Edge: Intracellular IFN-β and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells
Journal of Immunology
Allergy
Immunology
